Updated hourlyHourly refreshThu, Sep 17, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare · Energy
Take the Civilian Count Survey today if you are experiencing unexplained pain, abnormal neurological symptoms, cognitive changes, or unusual sensory disturbances. This national initiative, led by Direct Energy Weapons Agency, Inc. (DEWA), is documenting civilian-reported experiences to help inform public-health leaders, researchers, and policymakers. Your participation can help ensure that civilians experiencing these [PR.com]
Sep 9 · 17:04·PR.com
Healthcare
DENVER, CO, UNITED STATES, 2026-09-09 — /EPR Network/ — PlacidWay, an industry-leading international medical tourism and healthcare marketplace, today announced a strategic partnership with Stem [read full press release...]
Sep 9 · 16:49·Express Press Release
Healthcare
Pasadena, TX, 2026-09-09 — /EPR Network/ — Spencer Animal Hospital continues to provide comprehensive veterinary services to the Pasadena community, backed by an accreditation held [read full press release...]
Sep 9 · 16:47·Express Press Release
Healthcare
Manila, Philippines, 2026-09-09 — /EPR Network/ — LetsMeds, a trusted provider of specialty oncology medicines, has announced expanded access to Abiraterone Acetate and Enzalutamide medicines for [read full press release...]
Sep 9 · 16:43·Express Press Release
Healthcare
In the news release, Altesa BioSciences Presents Novel Clinical Data Demonstrating Vapendavir Significantly Reduces Key Inflammatory Biomarkers in Rhinovirus-Challenged COPD Patients at the European Respiratory Society International Congress 2026, issued 08-Sep-2026 by Altesa Biosciences...
Sep 9 · 16:38·PR Newswire
Healthcare
Clinical-stage biotechnology company adds approximately 900 new investors, expands its cap table to approximately 8,000, and brings total capital raised to $47 million JUPITER, Fla., Sept. 9, 2026 /PRNewswire/ -- Cytonics Corporation, a clinical-stage biotechnology company developing...
Sep 9 · 16:38·PR Newswire
Healthcare
Register now to save your spot for this free webinar on October 6, 2026, featuring leaders from Permanente Medical Groups and Tufts Medical Center. OAKLAND, Calif., Sept. 9, 2026 /PRNewswire/ -- National health care leaders from Kaiser Permanente and Tufts Medical Center will present a...
Sep 9 · 16:36·PR Newswire
SaaS · Healthcare
London, UK, 2026-09-09 — /EPR Network/ — The Global Clinical Trials Connect Conference is a premier platform bringing together global leaders, clinical researchers, regulatory experts, [read full press release...]
Sep 9 · 16:16·Express Press Release
Healthcare
(PR-inside.com) Biovica delivered 56% sales growth in the first quarter, driven by strong Pharma Services momentum, while taking decisive actions to streamline operations, strengthen leadership, and position the company for its next phase of growth. UPPSALA, SE / ACCESS Newswire / September 9, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Q1 (May 2026 - July 2026) (comparison figures are for the same period 2025/2026) Net sales amounted to KSEK 4,043(2,596), corresponding to an increase of 56%. In local currency, net sales increased by 57%. Operating Loss (EBIT) amounted to KSEK -20,334 (-19,334) including KSEK 2,200 (0) in restructuring costs. Cash flow from operating activities amounted to KSEK -16,100 ..
Sep 9 · 16:10·PR-Inside
Healthcare
Temecula, CA, 2026-09-09 — /EPR Network/ — Redzone Performance is foregrounding a clinically exacting model of hormone care that places diagnostic evidence ahead of symptom-based [read full press release...]
Sep 9 · 16:06·Express Press Release
Finance · Healthcare
New York, New York--(Newsfile Corp. - September 9, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Hims securities between August 4, 2025 and...
Sep 9 · 16:00·mlpr-newsfile
Healthcare
OSE Immunotherapeutics Welcomes First Patient Dosed by Veloxis in the Phase 2 RENGEVITY-201 Trial Evaluating Pegrizeprument (VEL-101)
Sep 9 · 16:00·GlobeNewswire